{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-013744","form_type":"8-K","ticker":"RLYB","cik":"0001739410","company_name":"Rallybio Corp","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.867681+00:00","generated_at":"2026-06-24T06:01:44.213939+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Rallybio appoints Wendy K. Chung, M.D., Ph.D., to its Board of Directors","bullets":["Board size increased from 9 to 10; Dr. Chung fills newly created vacancy effective Aug 1, 2022.","Dr. Chung appointed as Class III director with term expiring at 2024 annual meeting.","She will serve on the Nominating and Corporate Governance Committee.","Compensation follows standard non-employee director policy; no material transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-013744","json":"https://secwatch.observer/filing/0000950170-22-013744.json","markdown":"https://secwatch.observer/filing/0000950170-22-013744.md","text":"https://secwatch.observer/filing/0000950170-22-013744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/0000950170-22-013744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/rlyb-20220801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:01:44.213939+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a8a0744be","claim":"Wendy K. Chung, M.D., Ph.D. was appointed as director at Rallybio Corp.","evidence_excerpt":"the Board increased its size from nine directors to ten directors and appointed Wendy K. Chung, M.D., Ph.D. to serve as a director to fill the newly created vacancy, effective August 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739410/000095017022013744/0000950170-22-013744-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}